CAESAREA, Israel, September 8, 2011 /PRNewswire/ —
Angioslide Ltd. announces the first procedures with its new
5x300mm PROTEUS device for treating the Superficial Femoral Artery
(SFA). PROTEUS technology combines a Percutaneous
Transluminal Angioplasty (PTA) balloon and embolic capture of
particles in one device. The new 5×300 mm size joins Angioslide’s
current dedicated product line solutions for the lower limbs.
Initial treatments using the new PROTEUS device were conducted
in leading world centers, Parkkrankenhaus Leipzig and Herzzentrum
Bad Krozingen, located in Germany. The PROTEUS 5X300 mm makes it
possible to treat lesions up to 300 mm with one device, while
providing an immediate solution for embolic capture.
“Angioslide’s breakthrough technology, now available also in 300
mm length as well, is a unique solution for lesions with high level
of embolic material, including Chronic Total Occlusions (CTO), in
stent-restenosis, thrombus containing lesions and post atherectomy
PTA,” said Prof. Thomas Zeller, Head of the Angiology Department,
Heart Center Bad-Krozingen.
Prof. Dierk Scheinert, Head of the Department of Angiology,
Park-Krankenhaus Leipzig, adds, “We have been using the PROTEUS
product line as part of our daily practice for a few years, and are
working closely with the Angioslide team. I welcome the release of
the 5X300 mm. We can now use one device to treat patients
with SFA diseases, which facilitates the procedural flow and makes
the intervention cost-effective.”
With the increase in life expectancy, diabetes prevalence, and
number of high-risk patients, together with the shift toward
an “endovascular-first” approach as a preferred procedure over
surgical revascularization, there is a growing need for expanding
the current interventional “tool box” to accommodate procedures
designed specifically to treat long and diffuse lesions in a quick
and effective manner.
“We
‘/>”/>
